1
ANTIMICROBIAL AND RHEUMATOID ARTHRITIS DRUG PRINCIPLES,
MECHANISMS, RESISTANCE AND TREATMENT STRATEGIES LATEST 2025/2026
WITH REAL QUESTIONS AND DETAILED ANSWERS | COMPREHENSIVE NURSING
PHARMACOLOGY REVIEW | ANTIMICROBIAL THERAPY | RHEUMATOID
ARTHRITIS MEDICATIONS
Core Domains
1. Antimicrobial Principles: Spectrum, Selective Toxicity, and Resistance
2. Beta-Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems
3. Protein Synthesis Inhibitors: Macrolides, Tetracyclines, Aminoglycosides
4. Fluoroquinolones, Sulfonamides, and Miscellaneous Antibacterials
5. Antifungals, Antivirals, and Antimycobacterials
6. Rheumatoid Arthritis Pathophysiology and Inflammatory Mediators
7. NSAIDs, Corticosteroids, and Traditional DMARDs
8. Biologic DMARDs: TNF Inhibitors, IL-6 Inhibitors, T-cell Modulators
9. Targeted Synthetic DMARDs and JAK Inhibitors
10. Nursing Management, Patient Education, and Adverse Effect Monitoring
Introduction
This comprehensive pharmacology review integrates antimicrobial and
rheumatoid arthritis drug principles, mechanisms, resistance, and evidence-based
treatment strategies. The 100 multiple-choice questions are designed for nursing
students and practicing nurses preparing for exams or seeking to deepen clinical
knowledge. Content covers antibiotic classes, spectrum of activity, resistance
mechanisms, antifungal and antiviral agents, as well as the full range of RA
pharmacotherapy from NSAIDs and DMARDs to biologics and JAK inhibitors. Each
question incorporates real-world clinical scenarios emphasizing nursing
assessment, monitoring for adverse effects, and patient education. Detailed
rationales accompany every answer to reinforce learning and promote safe,
effective medication administration. Updated for the 2025/2026 cycle, this
resource ensures mastery of key pharmacologic concepts.
SECTION ONE: QUESTIONS 1–100
pg. 1
,2
1. A nurse is caring for a patient receiving vancomycin intravenously for a
methicillin-resistant Staphylococcus aureus (MRSA) infection. Which laboratory
value should be monitored to assess for a serious adverse effect of this
medication?
A. Serum creatinine and trough vancomycin levels
B. Liver function tests
C. Serum potassium
D. Blood glucose
A. Serum creatinine and trough vancomycin levels
RATIONALE: Vancomycin can cause nephrotoxicity, especially with high
trough levels (>20 mcg/mL) or prolonged therapy. Monitoring serum creatinine
and trough levels (goal 10–20 mcg/mL for severe infections) is essential. It is not
primarily hepatotoxic (B), nor does it commonly cause electrolyte disturbances (C)
or glucose changes (D). Ototoxicity is another concern, but renal function is the
primary monitoring parameter.
2. A patient with a history of severe penicillin allergy requires antibiotic therapy
for a Gram-negative infection. Which cephalosporin would be the safest choice?
A. Cefazolin
B. Ceftriaxone
C. Cephalexin
D. None; all cephalosporins carry a risk of cross-reactivity and should be avoided
in severe penicillin allergy.
D. None; all cephalosporins carry a risk of cross-reactivity and should be
avoided in severe penicillin allergy.
RATIONALE: Cross-reactivity between penicillins and cephalosporins is
approximately 1–3%, but in patients with a history of anaphylaxis or severe
reaction to penicillin, cephalosporins are generally contraindicated. The nurse
should consult the provider for an alternative such as a carbapenem (if not cross-
reactive), aztreonam, or a non-beta-lactam antibiotic.
3. Which of the following best explains the mechanism of action of
fluoroquinolones like ciprofloxacin?
A. Inhibition of bacterial cell wall synthesis
B. Inhibition of DNA gyrase and topoisomerase IV, blocking DNA replication
pg. 2
,3
C. Inhibition of protein synthesis by binding to the 30S ribosomal subunit
D. Disruption of the bacterial cell membrane
B. Inhibition of DNA gyrase and topoisomerase IV, blocking DNA replication
RATIONALE: Fluoroquinolones target bacterial enzymes essential for DNA
replication and repair. This mechanism gives them broad-spectrum activity. Beta-
lactams (A) inhibit cell wall synthesis, aminoglycosides/tetracyclines (C) bind to
ribosomal subunits, and polymyxins (D) disrupt the cell membrane.
4. A nurse is educating a patient who is starting methotrexate for rheumatoid
arthritis. Which statement by the patient indicates a need for further teaching?
A. “I will take folic acid as prescribed to help reduce side effects.”
B. “I can drink alcohol in moderation while taking this medication.”
C. “I need to have regular blood tests to check my liver and kidneys.”
D. “It may take several weeks to notice improvement in my joint symptoms.”
B. “I can drink alcohol in moderation while taking this medication.”
RATIONALE: Methotrexate is hepatotoxic, and concurrent alcohol use
significantly increases the risk of liver damage. Patients must avoid alcohol
entirely. The other statements are correct: folic acid reduces GI and mucosal side
effects, regular lab monitoring is essential, and onset of therapeutic effect may
take 4–8 weeks.
5. A patient with tuberculosis is started on a four-drug regimen of isoniazid,
rifampin, pyrazinamide, and ethambutol. The nurse explains that multi-drug
therapy is essential primarily to:
A. Reduce the cost of treatment
B. Shorten the duration of therapy to one month
C. Prevent the emergence of drug-resistant organisms
D. Increase the absorption of each drug
C. Prevent the emergence of drug-resistant organisms
RATIONALE: Mycobacterium tuberculosis has a high mutation rate, and
resistant mutants can emerge rapidly if a single drug is used. Combining multiple
drugs with different mechanisms reduces the likelihood that any one organism
will survive all agents. The standard duration is 6–9 months, not one month (B).
Cost and absorption are not the primary reasons.
pg. 3
, 4
6. A patient receiving gentamicin for a severe Gram-negative infection should be
monitored for which adverse effects?
A. Hepatotoxicity and hyperglycemia
B. Nephrotoxicity and ototoxicity
C. Cardiotoxicity and hypokalemia
D. Bone marrow suppression and peripheral neuropathy
B. Nephrotoxicity and ototoxicity
RATIONALE: Aminoglycosides like gentamicin are known for causing dose-
dependent nephrotoxicity (acute tubular necrosis) and irreversible ototoxicity
(cochlear and vestibular damage). Peak and trough levels are monitored to
minimize risk. They are not primarily hepatotoxic, cardiotoxic, or
myelosuppressive.
7. Which of the following statements about biologic DMARDs for rheumatoid
arthritis is true?
A. They can be administered orally.
B. They are considered first-line therapy for all newly diagnosed RA patients.
C. They target specific components of the immune system, such as TNF-alpha or
interleukin-6.
D. They have no risk of serious infections.
C. They target specific components of the immune system, such as TNF-alpha
or interleukin-6.
RATIONALE: Biologics are large-molecule proteins administered parenterally
(subcutaneous or IV), not orally (A). They are reserved for moderate-to-severe RA
after inadequate response to traditional DMARDs like methotrexate (B). Because
they suppress the immune system, they carry an increased risk of serious
infections, including tuberculosis reactivation (D). They are targeted therapies.
8. A patient is prescribed doxycycline for a tick-borne infection. Which nursing
instruction is most important?
A. “Take this medication with a full glass of milk to prevent stomach upset.”
B. “Avoid prolonged sun exposure and use sunscreen, as this drug can cause
photosensitivity.”
C. “Stop taking the medication once the fever resolves.”
D. “Take this medication on an empty stomach with a full glass of water, and
pg. 4
ANTIMICROBIAL AND RHEUMATOID ARTHRITIS DRUG PRINCIPLES,
MECHANISMS, RESISTANCE AND TREATMENT STRATEGIES LATEST 2025/2026
WITH REAL QUESTIONS AND DETAILED ANSWERS | COMPREHENSIVE NURSING
PHARMACOLOGY REVIEW | ANTIMICROBIAL THERAPY | RHEUMATOID
ARTHRITIS MEDICATIONS
Core Domains
1. Antimicrobial Principles: Spectrum, Selective Toxicity, and Resistance
2. Beta-Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems
3. Protein Synthesis Inhibitors: Macrolides, Tetracyclines, Aminoglycosides
4. Fluoroquinolones, Sulfonamides, and Miscellaneous Antibacterials
5. Antifungals, Antivirals, and Antimycobacterials
6. Rheumatoid Arthritis Pathophysiology and Inflammatory Mediators
7. NSAIDs, Corticosteroids, and Traditional DMARDs
8. Biologic DMARDs: TNF Inhibitors, IL-6 Inhibitors, T-cell Modulators
9. Targeted Synthetic DMARDs and JAK Inhibitors
10. Nursing Management, Patient Education, and Adverse Effect Monitoring
Introduction
This comprehensive pharmacology review integrates antimicrobial and
rheumatoid arthritis drug principles, mechanisms, resistance, and evidence-based
treatment strategies. The 100 multiple-choice questions are designed for nursing
students and practicing nurses preparing for exams or seeking to deepen clinical
knowledge. Content covers antibiotic classes, spectrum of activity, resistance
mechanisms, antifungal and antiviral agents, as well as the full range of RA
pharmacotherapy from NSAIDs and DMARDs to biologics and JAK inhibitors. Each
question incorporates real-world clinical scenarios emphasizing nursing
assessment, monitoring for adverse effects, and patient education. Detailed
rationales accompany every answer to reinforce learning and promote safe,
effective medication administration. Updated for the 2025/2026 cycle, this
resource ensures mastery of key pharmacologic concepts.
SECTION ONE: QUESTIONS 1–100
pg. 1
,2
1. A nurse is caring for a patient receiving vancomycin intravenously for a
methicillin-resistant Staphylococcus aureus (MRSA) infection. Which laboratory
value should be monitored to assess for a serious adverse effect of this
medication?
A. Serum creatinine and trough vancomycin levels
B. Liver function tests
C. Serum potassium
D. Blood glucose
A. Serum creatinine and trough vancomycin levels
RATIONALE: Vancomycin can cause nephrotoxicity, especially with high
trough levels (>20 mcg/mL) or prolonged therapy. Monitoring serum creatinine
and trough levels (goal 10–20 mcg/mL for severe infections) is essential. It is not
primarily hepatotoxic (B), nor does it commonly cause electrolyte disturbances (C)
or glucose changes (D). Ototoxicity is another concern, but renal function is the
primary monitoring parameter.
2. A patient with a history of severe penicillin allergy requires antibiotic therapy
for a Gram-negative infection. Which cephalosporin would be the safest choice?
A. Cefazolin
B. Ceftriaxone
C. Cephalexin
D. None; all cephalosporins carry a risk of cross-reactivity and should be avoided
in severe penicillin allergy.
D. None; all cephalosporins carry a risk of cross-reactivity and should be
avoided in severe penicillin allergy.
RATIONALE: Cross-reactivity between penicillins and cephalosporins is
approximately 1–3%, but in patients with a history of anaphylaxis or severe
reaction to penicillin, cephalosporins are generally contraindicated. The nurse
should consult the provider for an alternative such as a carbapenem (if not cross-
reactive), aztreonam, or a non-beta-lactam antibiotic.
3. Which of the following best explains the mechanism of action of
fluoroquinolones like ciprofloxacin?
A. Inhibition of bacterial cell wall synthesis
B. Inhibition of DNA gyrase and topoisomerase IV, blocking DNA replication
pg. 2
,3
C. Inhibition of protein synthesis by binding to the 30S ribosomal subunit
D. Disruption of the bacterial cell membrane
B. Inhibition of DNA gyrase and topoisomerase IV, blocking DNA replication
RATIONALE: Fluoroquinolones target bacterial enzymes essential for DNA
replication and repair. This mechanism gives them broad-spectrum activity. Beta-
lactams (A) inhibit cell wall synthesis, aminoglycosides/tetracyclines (C) bind to
ribosomal subunits, and polymyxins (D) disrupt the cell membrane.
4. A nurse is educating a patient who is starting methotrexate for rheumatoid
arthritis. Which statement by the patient indicates a need for further teaching?
A. “I will take folic acid as prescribed to help reduce side effects.”
B. “I can drink alcohol in moderation while taking this medication.”
C. “I need to have regular blood tests to check my liver and kidneys.”
D. “It may take several weeks to notice improvement in my joint symptoms.”
B. “I can drink alcohol in moderation while taking this medication.”
RATIONALE: Methotrexate is hepatotoxic, and concurrent alcohol use
significantly increases the risk of liver damage. Patients must avoid alcohol
entirely. The other statements are correct: folic acid reduces GI and mucosal side
effects, regular lab monitoring is essential, and onset of therapeutic effect may
take 4–8 weeks.
5. A patient with tuberculosis is started on a four-drug regimen of isoniazid,
rifampin, pyrazinamide, and ethambutol. The nurse explains that multi-drug
therapy is essential primarily to:
A. Reduce the cost of treatment
B. Shorten the duration of therapy to one month
C. Prevent the emergence of drug-resistant organisms
D. Increase the absorption of each drug
C. Prevent the emergence of drug-resistant organisms
RATIONALE: Mycobacterium tuberculosis has a high mutation rate, and
resistant mutants can emerge rapidly if a single drug is used. Combining multiple
drugs with different mechanisms reduces the likelihood that any one organism
will survive all agents. The standard duration is 6–9 months, not one month (B).
Cost and absorption are not the primary reasons.
pg. 3
, 4
6. A patient receiving gentamicin for a severe Gram-negative infection should be
monitored for which adverse effects?
A. Hepatotoxicity and hyperglycemia
B. Nephrotoxicity and ototoxicity
C. Cardiotoxicity and hypokalemia
D. Bone marrow suppression and peripheral neuropathy
B. Nephrotoxicity and ototoxicity
RATIONALE: Aminoglycosides like gentamicin are known for causing dose-
dependent nephrotoxicity (acute tubular necrosis) and irreversible ototoxicity
(cochlear and vestibular damage). Peak and trough levels are monitored to
minimize risk. They are not primarily hepatotoxic, cardiotoxic, or
myelosuppressive.
7. Which of the following statements about biologic DMARDs for rheumatoid
arthritis is true?
A. They can be administered orally.
B. They are considered first-line therapy for all newly diagnosed RA patients.
C. They target specific components of the immune system, such as TNF-alpha or
interleukin-6.
D. They have no risk of serious infections.
C. They target specific components of the immune system, such as TNF-alpha
or interleukin-6.
RATIONALE: Biologics are large-molecule proteins administered parenterally
(subcutaneous or IV), not orally (A). They are reserved for moderate-to-severe RA
after inadequate response to traditional DMARDs like methotrexate (B). Because
they suppress the immune system, they carry an increased risk of serious
infections, including tuberculosis reactivation (D). They are targeted therapies.
8. A patient is prescribed doxycycline for a tick-borne infection. Which nursing
instruction is most important?
A. “Take this medication with a full glass of milk to prevent stomach upset.”
B. “Avoid prolonged sun exposure and use sunscreen, as this drug can cause
photosensitivity.”
C. “Stop taking the medication once the fever resolves.”
D. “Take this medication on an empty stomach with a full glass of water, and
pg. 4
